浏览全部资源
扫码关注微信
上海中医药大学 附属曙光医院,上海 200120
Published:20 March 2023,
Published Online:13 September 2022,
Received:19 April 2022,
扫 描 看 全 文
徐磊,樊炜静,王徐红等.复方黄柏液中医外治溻渍法治疗Wagner1~2级糖尿病足的临床观察[J].中国实验方剂学杂志,2023,29(06):104-110.
XU Lei,FAN Weijing,WANG Xuhong,et al.Clinical Observation on Treatment of Diabetic Foot Ulcer of Wagner Grade 1-2 by Compound Huangbai Liquid Fomentation[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(06):104-110.
徐磊,樊炜静,王徐红等.复方黄柏液中医外治溻渍法治疗Wagner1~2级糖尿病足的临床观察[J].中国实验方剂学杂志,2023,29(06):104-110. DOI: 10.13422/j.cnki.syfjx.202202125.
XU Lei,FAN Weijing,WANG Xuhong,et al.Clinical Observation on Treatment of Diabetic Foot Ulcer of Wagner Grade 1-2 by Compound Huangbai Liquid Fomentation[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(06):104-110. DOI: 10.13422/j.cnki.syfjx.202202125.
目的
2
观察复方黄柏液中医外治溻渍法治疗Wagner1~2级糖尿病足溃疡的临床疗效。
方法
2
通过使用随机对照试验设计的方式,将两组患者分为观察组与对照组,每组41例,两组患者在采用常规治疗的基础上分别采用复方黄柏液中医外治溻渍法与纳米银医用抗菌敷料的治疗方式,并观察两组患者治疗前后的溃疡面积、溃疡深度、中医证候评分、踝肱指数、经皮氧分压、血管内皮生长因子、表皮生长因子、晚期糖基化终末产物、超敏C-反应蛋白、白细胞介素-6、红细胞沉降率、不良事件。
结果
2
与本组治疗前比较,两组患者治疗后溃疡面积、溃疡深度、中医证候评分、晚期糖基化终末产物、超敏C-反应蛋白、白细胞介素-6、红细胞沉降率均明显降低(
P
<
0.05),踝肱指数、经皮氧分压、血管内皮生长因子、表皮生长因子均明显升高(
P
<
0.05);治疗后与对照组比较,观察组溃疡面积、溃疡深度、中医证候评分、血管内皮生长因子、表皮生长因子、晚期糖基化终末产物、超敏C-反应蛋白、白细胞介素-6、红细胞沉降率明显降低(
P
<
0.05),踝肱指数、经皮氧分压、血管内皮生长因子、表皮生长因子明显升高(
P
<
0.05);观察组临床疗效优于对照组(
χ
2
=4.561,
P
<
0.05);两组不良事件与终点事件发生差异无统计学意义。
结论
2
复方黄柏液中医外治溻渍法对Wagner1~2级糖尿病足溃疡的治疗有显著效果,有利于促进糖尿病足溃疡的愈合,为复方黄柏液与中药溻渍法的进一步临床推广提供了临床证据。
Objective
2
To observe the clinical efficacy of compound Huangbai liquid fomentation on diabetic foot ulcer of Wagner grade 1-2.
Method
2
Patients were classified into the observation group and control group, with 41 cases in either group. The observation group received routine therapy and compound Huangbai liquid fomentation, while the control group was treated by routine therapy and medical silver nanoparticles-containing dressing. Ulcer area, ulcer depth, traditional Chinese medicine (TCM) syndrome score, ankle-brachial index, transcutaneous oxygen pressure, vascular endothelial growth factor, epidermal growth factor, advanced glycation end product, high-sensitivity C-reactive protein, interleukin-6, erythrocyte sedimentation rate, and adverse events were observed before and after treatment in two groups.
Result
2
After treatment, the ulcer area, ulcer depth, TCM syndrome score, vascular endothelial growth factor, epidermal growth factor, advanced glycation end product, high-sensitivity C-reactive protein, interleukin-6(IL-6), and erythrocyte sedimentation rate were lower than those before treatment in two groups (
P
<
0.05), and ankle-brachial index, transcutaneous oxygen pressure, vascular endothelial growth factor, and epidermal growth factor were higher than those before treatment in two groups (
P
<
0.05). After treatment, the ulcer area, ulcer depth, TCM syndrome score, advanced glycation end product, high-sensitivity C-reactive protein, IL-6, and erythrocyte sedimentation rate were lower in the observation group than in the control group (
P
<
0.05), and ankle-brachial index, transcutaneous oxygen pressure, vascular endothelial growth factor, and epidermal growth factor were higher in the observation group than in the control group (
P
<
0.05). The clinical efficacy of observation group was better than that of the control group (
P
<
0.05). There was no significant difference in the incidence of adverse events and endpoint events between two groups.
Conclusion
2
Compound Huangbai liquid fomentation is effective for diabetic foot ulcer of Wagner grade 1-2, as it is beneficial to the healing of the ulcer. This study provides clinical evidence for the further promotion of Chinese medicine fomentation.
糖尿病足溃疡Wagner1~2级复方黄柏液中药溻渍法中医外治
diabetic foot ulcerWagner grade 1-2compound Huangbai liquidChinese medicine fomentationexternal treatment of Chinese medicine
CHAN J C N,LIM L L,WAREHAM N J,et al. The lancet commission on diabetes:Using data to transform diabetes care and patient lives[J]. Lancet,2021,396(10267):2019-2082.
SCHAPER N C, VAN NETTEN J J,APELQVIST J,et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)[J].Diabetes Metab Res Rev,2020,36(Suppl 1):e3266.
LIPSKY B A,SENNEVILLE É,ABBAS Z G,et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)[J].Diabetes Metab Res Rev,2020,36(Suppl 1):e3280.
郭光华,朱峰,闵定宏,等.糖尿病足合并难愈性创面外科治疗全国专家共识(2020版)[J]. 中华损伤与修复杂志:电子版,2020,15(4): 256-263.
NIKOLOUDI M,ELEFTHERIADOU I,TENTOLOURIS A,et al. Diabetic foot infections: Update on management[J].Curr Infect Dis Rep,2018,20(10):40.
李友山,杨博华.“蚓黄散”干预糖尿病足溃疡愈合过程中AGEs与促愈合因子相关性研究[J].世界科学技术—中医药现代化,2015,17(2):350-355.
ZHOU X,GUO Y L,YANG K,et al. The signaling pathways of traditional Chinese medicine in promoting diabetic wound healing[J].J Ethnopharmacol,2022, doi:10.1016/j.jep.2021.114662http://dx.doi.org/10.1016/j.jep.2021.114662.
张伟,于占江,金立.清热解毒活血通络方联合复方黄柏液对糖尿病足患者的疗效分析[J].中国实验方剂学杂志,2016,22(12):177-181.
徐潇,崔炎,王坤,等. 中药溻渍在周围血管疾病中的应用[J]. 中国民间疗法,2020,28(11):102-104.
樊炜静,韩强,黄仁燕,等.近10年中药溻渍法临床研究的文献计量学分析[J].中国中医基础医学杂志,2021,27(3):480-483,512.
谷涌泉. 中国糖尿病足诊治指南[J].中国临床医生杂志,2020,48(1):19-27.
WAGNER F W.The dysvascular foot: A system for diagnosis and treatment[J].Foot Ankle,1981,2(2):64-122.
陆灏,倪青,柳国斌,等. 糖尿病足病中医病证结合诊疗指南[J].中医杂志,2021,62(12):1099-1104.
孙波,王万春,张乃忻,等.愈疡生肌膏治疗Wagner 1~2级糖尿病足临床疗效观察[J].中华中医药杂志,2021,36(5):3053-3055.
中国中西医结合学会周围血管病专业委员会.中西医结合防治糖尿病足中国专家共识(第1版)[J].血管与腔内血管外科杂志,2019,5(5):379-402.
高杰,杜亚丽,王艳阳,等.踝肱指数与糖尿病足创面预后良好时间的关系[J].微循环学杂志,2020,30(3):33-35.
国家中医药管理局.中华人民共和国中医药行业标准——中医病证诊断疗效标准[M].南京:南京大学出版社,1994:243-244.
ARMSTRONG D G,BOULTON A,BUS S A. Diabetic foot ulcers and their recurrence[J].N Engl J Med,2017,376(24):2367-2375.
孙子林,陆军,徐治,等. 糖尿病足基层筛查与防治专家共识[J].中国糖尿病杂志,2019,27(6):401-407.
IBRAHIM A. IDF Clinical practice recommendation on the diabetic foot:A guide for healthcare professionals[J].Diabetes Res Clin Pract,2017,doi: 10.1016/j.diabres.2017.04.013http://dx.doi.org/10.1016/j.diabres.2017.04.013.
GHARABOGHAZ M,FARAHPOUR M R,SAGHAIE S. Topical co-administration of Teucrium polium hydroethanolic extract and Aloe vera gel triggered wound healing by accelerating cell proliferation in diabetic mouse model[J].Biomed Pharmacother,2020,127:110189.
DAEMI A,LOTFI M,FARAHPOUR M R,et al. Topical application of Cinnamomum hydroethanolic extract improves wound healing by enhancing re-epithelialization and keratin biosynthesis in streptozotocin-induced diabetic mice [J].Pharm Biol,2019,57(1):799-806.
DARDMAH F,FARAHPOUR M R. Quercus infectoria gall extract aids wound healing in a streptozocin-induced diabetic mouse model[J].J Wound Care,2021,30(8):618-625.
YAZARLU O,IRANSHAHI M,KASHANI H R K,et al. Perspective on the application of medicinal plants and natural products in wound healing: A mechanistic review[J].Pharmacol Res,2021,doi: 10.1016/j.phrs.2021.105841http://dx.doi.org/10.1016/j.phrs.2021.105841.
陈鑫,刘政,郭道成.中药溻渍疗法治疗糖尿病足溃疡研究进展[J].中国中西医结合外科杂志,2018,24(6):797-799.
张敏芝. 脉络舒通颗粒外洗对促进糖尿病足慢性溃疡愈合的临床疗效研究[J].双足与保健,2019,28(7):48-49.
任盛静,郑德.中药溻渍法研究概述[J].中医学报,2017,32(10):1895-1897.
王雪,王伟,王萍,等. 糖尿病足感染患者血清miRNA表达与创面修复因子及免疫功能的关系[J].中华医院感染学杂志,2021,31(22): 3422-3426.
李凌霄,徐俊,王鹏华,等. 复方黄柏液局部应用对糖尿病足溃疡愈合的临床研究[J].重庆医科大学学报,2017,42(3):289-294.
褚璐,胡少锋,张志华,等.血清超敏C-反应蛋白在糖尿病足感染患者中变化及临床意义[J].中华医院感染学杂志,2014,24(13):3273-3275.
宋振强,王润秀,于德民,等.晚期糖基化终末产物修饰人血清白蛋白对离体角质形成细胞迁移功能的影响[J].中华医学杂志,2008,88(38):2690-2694.
牛轶雯,陆树良.晚期糖基化终末产物受体与创伤修复[J].感染、炎症、修复,2005,6(4):230-232.
郑琪,李友山,冀凌云. 复方黄柏液促进糖尿病足溃疡愈合及其中AGEs与炎性因子的相关性[J]. 中国实验方剂学杂志,2016,22(24):167-171.
0
Views
19
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution